Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.96 +0.22 (+0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Income from Non-Controlling Interests (2014 - 2015)

Updated

Ligand Pharmaceuticals' Income from Non-Controlling Interests was $2.38 million in FY2015, compared with -$1.13 million in FY2014.

Analysis

Ligand Pharmaceuticals (LGND) Income from Non-Controlling Interests (2014 - 2015) Analysis & Trends

  • Per Business Quant data, Income from Non-Controlling Interests in earlier years was -$1.13 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 10.00 Mn
10 Ligand Pharmaceuticals 6.03 Bn 2.50 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 -1.54 Mn
Mar 31, 2015 -843,000.00
Dec 31, 2014 -325,000.00
Sep 30, 2014 -503,000.00
Jun 30, 2014 -304,000.00
API Access

Ligand Pharmaceuticals Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=LGND&period=max&api_key=YOUR_API_KEY